Nova Patents
PL323866A1

Application of derivatives of vitamin d4 in treating carcinoma

Abstract

Novel 1 alpha -hydroxy vitamin D4 and novel analogues, and preferably 1,24 dihydroxy vitamin D4, which are useful as active compounds of pharmaceutical compositions for the treatment of disorders of calcium metabolism and breast and colon cancers.

Term

Term ended

Projected expiry passed 6 June 2016, 10.3 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

247 members in 26 offices

This recordMember, by publication datePriority claim16 more offices are in the list below

Priority claims4

Priority claims
DocumentOfficeKindDate
48638795United States of AmericaA
48638795United States of AmericaA
486387–––
US19950486387–––

Members247

Family members, oldest first
DocumentOfficeKind
WO9001321A2World Intellectual Property Organization (WIPO)A2
AU4220389AAustraliaA
SE9001308D0SwedenD0
SE9001308LSwedenL
WO9001321A3World Intellectual Property Organization (WIPO)A3
NL8920901ANetherlands (Kingdom of the)A
DE3990902T1GermanyT1
EP0381750A1European Patent Office (EPO)A1
GB9006990D0United KingdomD0
GB2231794AUnited KingdomA
JPH03501388AJapanA
GB2231794BUnited KingdomB
CA2069084A1CanadaA1
WO9205130A1World Intellectual Property Organization (WIPO)A1
US5104864AUnited States of AmericaA
AU8542291AAustraliaA
MX9101224AMexicoA
NO921955D0NorwayD0
CN1061220AChinaA
NO921955LNorwayL
ZA917553BSouth AfricaB
MX9203760AMexicoA
EP0503035A1European Patent Office (EPO)A1
HU9201691D0HungaryD0
KR920703487ARepublic of KoreaA
AU634490B2AustraliaB2
BR9106062ABrazilA
HUT62559AHungaryA
CA2129120A1CanadaA1
WO9314763A1World Intellectual Property Organization (WIPO)A1
AU3656193AAustraliaA
PL294706A1PolandA1
EP0503035A4European Patent Office (EPO)A4
AU650286B2AustraliaB2
EP0381750B1European Patent Office (EPO)B1
AT114471TAustriaT
ATE114471T1AustriaT1
EP0631500A1European Patent Office (EPO)A1
DE68919673D1GermanyD1
US5403831AUnited States of AmericaA
JPH07503714AJapanA
AR247817A1ArgentinaA1
DE68919673T2GermanyT2
EP0631500A4European Patent Office (EPO)A4
HU211963A9HungaryA9
US5488120AUnited States of AmericaA
NZ239897ANew ZealandA
CN1032255CChinaC
CN1130507AChinaA
CA2217260A1CanadaA1
WO9631215A1World Intellectual Property Organization (WIPO)A1
AU5384096AAustraliaA
CN1136433AChinaA
CA2222591A1CanadaA1
CA2222593A1CanadaA1
WO9640153A1World Intellectual Property Organization (WIPO)A1
WO9640154A1World Intellectual Property Organization (WIPO)A1
AU6256996AAustraliaA
AU6379196AAustraliaA
PL170447B1PolandB1
US5602116AUnited States of AmericaA
HU213471BHungaryB
NO974480D0NorwayD0
FI973868AFinlandA
AU682817B2AustraliaB2
NO974480LNorwayL
US5707980AUnited States of AmericaA
EP0820290A1European Patent Office (EPO)A1
PL322613A1PolandA1
EP0831838A1European Patent Office (EPO)A1
EP0831839A1European Patent Office (EPO)A1
EP0631500B1European Patent Office (EPO)B1
PL323798A1PolandA1
PL323866A1This recordPolandA1
US5756783AUnited States of AmericaA
DE69318142D1GermanyD1
BR9604940ABrazilA
US5763428AUnited States of AmericaA
US5763429AUnited States of AmericaA
CN1185109AChinaA
MX9709683AMexicoA
MX9709684AMexicoA
CN1186435AChinaA
CA2276606A1CanadaA1
WO9829123A1World Intellectual Property Organization (WIPO)A1
AU5595698AAustraliaA
MX9707535AMexicoA
US5798345AUnited States of AmericaA
US5801164AUnited States of AmericaA
DE69318142T2GermanyT2
KR19980703537ARepublic of KoreaA
HU9801777A2HungaryA2
HUP9801777A2HungaryA2
US5861386AUnited States of AmericaA
US5869473AUnited States of AmericaA
JPH11503164AJapanA
KR19990022320ARepublic of KoreaA
HK1008180A1Hong Kong, ChinaA1
HU9801777A3HungaryA3
HUP9801777A3HungaryA3
Showing 100 of 247